Search details
1.
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile.
Clin Infect Dis
; 75(1): e792-e804, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34537835
2.
Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice.
Immunology
; 158(4): 322-339, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31509246
3.
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.
Front Immunol
; 15: 1372193, 2024.
Article
in English
| MEDLINE | ID: mdl-38812507
4.
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.
EBioMedicine
; 91: 104563, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37099842
5.
Female offspring gestated in hypothyroxinemia and infected with human Metapneumovirus (hMPV) suffer a more severe infection and have a higher number of activated CD8+ T lymphocytes.
Front Immunol
; 13: 966917, 2022.
Article
in English
| MEDLINE | ID: mdl-36159799
6.
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.
medRxiv
; 2022 Feb 07.
Article
in English
| MEDLINE | ID: mdl-35441179
7.
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.
Elife
; 112022 10 13.
Article
in English
| MEDLINE | ID: mdl-36226829
8.
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.
mBio
; 13(6): e0131122, 2022 12 20.
Article
in English
| MEDLINE | ID: mdl-36383021
9.
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.
mBio
; 13(4): e0142322, 2022 08 30.
Article
in English
| MEDLINE | ID: mdl-35946814
10.
A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
Front Immunol
; 12: 664212, 2021.
Article
in English
| MEDLINE | ID: mdl-33981309
11.
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
Front Immunol
; 12: 742914, 2021.
Article
in English
| MEDLINE | ID: mdl-34659237
12.
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Front Immunol
; 12: 747830, 2021.
Article
in English
| MEDLINE | ID: mdl-34858404
13.
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.
medRxiv
; 2021 Apr 01.
Article
in English
| MEDLINE | ID: mdl-35441164
14.
Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus.
Front Microbiol
; 10: 873, 2019.
Article
in English
| MEDLINE | ID: mdl-31130923
Results
1 -
14
de 14
1
Next >
>>